Pain, pain go away: Scilex Pharmaceuticals snags $5 million for lidocaine patch
Specialty pain meds maker Scilex Pharmaceuticals plans to wrap up clinical trials for its lead product, Ztildo – and has just raised $5 million from private investors to do so, according to regulatory filings. Ztildo is a lidocaine patch developed specifically for a form of neuralgia that often follows shingles infections. It has licensed the technology from a […]